The influence of peri-implant mucosal phenotype on marginal bone changes in single-tooth implants with direct restorations: a 36-month clinical trial.

OBJECTIVES

This clinical trial aimed to evaluate changes at the marginal bone level by analysing the influence of the peri‑implant mucosal phenotype on implants restored with direct screw-retained prostheses after a 3-year follow-up.

METHODS

Fifty-one patients received 56 implants in the posterior part of the maxilla or mandible. The implants were placed equicrestally, 1 mm subcrestally (SC), or > 1 mm SC, depending on the initial supracrestal tissue height (STH). After 3 months of non-submerged healing, screw-retained single-unit crowns were placed in direct connection with the implant shoulder. Clinical (STH, mucosal thickness, and keratinised mucosa width, KMW) and radiographic (marginal bone remodelling and marginal bone loss, MBR and MBL, respectively) data were recorded during the implant placement surgery (T0) and at the 3, 6, 12, and 36-month follow-ups (T1-T4). MBL was considered the main variable in this work.

RESULTS

There was a significant reduction in the mean KMW (by 0.3 ± 0.7 mm) between the 12 and 36-month follow-up (p = .001). After 36 months, significant MBR had occurred between the T3 and T4 periods (0.15 ± 0.29 mm; p = .001), however there had also been some non-significant MBL. Implants with SC positioning > 1 mm showed the highest MBR levels, while equicrestal implants showed the highest MBL. Multiple linear regression analysis indicated that MBR is driven chiefly by implant length, implant diameter and the implant's apico-coronal position, whereas MBL depends mainly on KMW and implant diameter.

CONCLUSIONS

Implant crestal position, implant diameter, and keratinised mucosal width were the most important factors in marginal peri‑implant bone loss.

CLINICAL SIGNIFICANCE

The peri‑implant soft-tissue phenotype, specifically the KMW, seems to be the main protective factor against peri‑implant bone loss.